(*) EU Approval Date: 2019. 04.03.
(*) USA Approval Date: 2018. 09.27.
>EGFR exon 19 deletion or exon 21>
Company
kinase inhibitor
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2018. 10.23.
TradeMark
TradeMark Web-Site